Literature DB >> 25538272

Involvement of nitric oxide in the mitochondrial action of efavirenz: a differential effect on neurons and glial cells.

Nadezda Apostolova1, Haryes A Funes2, Ana Blas-Garcia3, Fernando Alegre3, Miriam Polo3, Juan V Esplugues4.   

Abstract

The anti-human immunodeficiency virus (HIV) drug efavirenz (EFV) alters mitochondrial function in cultured neurons and glial cells. Nitric oxide (NO) is a mediator of mitochondrial dysfunction associated with HIV central nervous system symptoms. We show that EFV promotes inducible nitric oxide synthase (iNOS) expression in cultured glial cells and generated NO undermines their mitochondrial function, as inhibition of NOS partially reverses this effect. EFV inhibits mitochondrial Complex I in both neurons and glia; however, when the latter cells are treated for longer periods, other mitochondrial complexes are also affected in accordance with the increased NO production. These findings shed light on the mechanisms responsible for the frequent EFV-associated neurotoxicity.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; NNRTI; central nervous system; efavirenz; electron transport chain; mitochondria; nitric oxide

Mesh:

Substances:

Year:  2014        PMID: 25538272     DOI: 10.1093/infdis/jiu825

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Neuropsychiatric Effects of HIV Antiviral Medications.

Authors:  Glenn J Treisman; Olivia Soudry
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

3.  Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz.

Authors:  Luc Bertrand; Michal Toborek
Journal:  Mol Pharmacol       Date:  2015-05-18       Impact factor: 4.436

Review 4.  Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

Authors:  Luc Bertrand; Madhavan Nair; Michal Toborek
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 5.  Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.

Authors:  Ankit Shah; Mohitkumar R Gangwani; Nitish S Chaudhari; Alexy Glazyrin; Hari K Bhat; Anil Kumar
Journal:  Neurotox Res       Date:  2016-06-30       Impact factor: 3.911

Review 6.  Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches.

Authors:  Jordan G Schnoll; Brian Temsamrit; Daniel Zhang; Hongjun Song; Guo-Li Ming; Kimberly M Christian
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-11       Impact factor: 4.147

Review 7.  The far-reaching HAND of cART: cART effects on astrocytes.

Authors:  Hemil Gonzalez; Anthony Podany; Lena Al-Harthi; Jennillee Wallace
Journal:  J Neuroimmune Pharmacol       Date:  2020-03-09       Impact factor: 7.285

8.  Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I.

Authors:  Naoki Imaizumi; Kang Kwang Lee; Carmen Zhang; Urs A Boelsterli
Journal:  Redox Biol       Date:  2015-01-16       Impact factor: 11.799

Review 9.  Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury.

Authors:  Nina Y Yuan; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-06       Impact factor: 4.147

10.  Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression.

Authors:  Leah H Rubin; Pauline M Maki; Gayle Springer; Lorie Benning; Kathryn Anastos; Deborah Gustafson; Maria C Villacres; Xiong Jiang; Adaora A Adimora; Drenna Waldrop-Valverde; David E Vance; Hector Bolivar; Christine Alden; Eileen M Martin; Victor G Valcour
Journal:  Neurology       Date:  2017-09-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.